Best Inflammatory Bowel Disease Treatment Doctors in India
Dr. Murugan N
Whatsapp Us
Dr. (Col) Avnish Seth
Dr. Sanjiv Saigal
Dr. Charles Panackel
Dr. Mallikarjun Sakpal
Dr. Narendra Singh Choudhary
Dr. Geeta Malkan Billa
What Patients with Inflammatory Bowel Disease Worry About Most
Inflammatory bowel disease covers Crohn disease and ulcerative colitis, two long-term conditions where the immune system attacks the gut. Patients worry about lifelong medication, about steroid side effects, about needing surgery and a stoma, and about how the diagnosis will affect work, fertility, and family life. Many are young and have already had urgent admissions for bleeding, pain, or weight loss. The honest position is that modern targeted therapy has changed the outlook in inflammatory bowel disease. Deep remission is realistic for most patients, and surgery, when needed, can be done laparoscopically with excellent results.
How Inflammatory Bowel Disease Is Diagnosed
Diagnosis combines symptoms (chronic diarrhoea, blood in stool, abdominal pain, weight loss, perianal disease) with endoscopy, imaging, and histology. Ileocolonoscopy with multiple biopsies is the cornerstone, defining the type, extent, and severity of disease. Magnetic resonance enterography assesses small bowel Crohn disease and complications such as strictures and fistulae. Faecal calprotectin is a useful non-invasive marker of bowel inflammation. Blood tests include haemoglobin, C-reactive protein, ferritin, vitamin B12, vitamin D, and liver function. Stool cultures rule out infection at diagnosis and at flare.
Treatment Options for Inflammatory Bowel Disease in India
Treatment is matched to type, location, severity, and risk of progression. Aminosalicylates such as mesalazine remain first-line for mild ulcerative colitis. Corticosteroids (prednisolone, budesonide) are used for short courses to induce remission. Steroid-sparing immunomodulators include azathioprine and methotrexate. Biologic agents are now central: anti-tumour necrosis factor drugs (infliximab, adalimumab), anti-integrin (vedolizumab), and anti-interleukin therapy (ustekinumab, risankizumab). Janus kinase inhibitors (tofacitinib, upadacitinib) are oral options for ulcerative colitis. Surgery (colectomy, ileal pouch-anal anastomosis, ileocaecal resection, stricturoplasty, fistula surgery) is needed in around twenty percent of ulcerative colitis and fifty percent of Crohn disease patients over time. Fortis Memorial Research Institute, Medanta, Apollo Hospitals, Asian Institute of Gastroenterology, Sir Ganga Ram Hospital, and All India Institute of Medical Sciences run dedicated inflammatory bowel disease clinics.
Recovery, Success Rates, and Follow-Up
Anti-tumour necrosis factor therapy induces remission in around sixty to seventy percent of patients with moderate-to-severe inflammatory bowel disease, with around half maintaining response at one year. Newer biologic agents have given options for patients who fail anti-tumour necrosis factor therapy. Laparoscopic ileocaecal resection has very good long-term outcomes and is often preferred over biologic therapy for short-segment ileal Crohn disease. Long-term follow-up includes scheduled blood tests, faecal calprotectin, endoscopy for mucosal healing assessment, and surveillance colonoscopy for colon cancer in long-standing colitis.
How to Choose the Right Gastroenterologist for Inflammatory Bowel Disease
Ask about the centre’s experience with the full range of biologic agents and Janus kinase inhibitors, access to therapeutic drug monitoring, and the link with a colorectal surgeon for ileal pouch-anal anastomosis or fistula surgery. Ask about the role of multidisciplinary inflammatory bowel disease meetings, the personalised plan, and what happens during a flare. Ask about pregnancy planning, vaccination, and the dietitian and psychology support that comes with long-term care.
International Patient Support
International patients receive a single coordinator who arranges appointments, ileocolonoscopy, magnetic resonance enterography, and biologic therapy. The Cancer Rounds team supports medical visa invitation letters, accommodation near the hospital, airport transfers, and multilingual support in eleven plus languages. Patients arrive from Nigeria, Bangladesh, Kenya, Ethiopia, Iraq, Oman, and the United Arab Emirates for inflammatory bowel disease care. A written long-term plan and cost estimate are shared before travel.
Frequently Asked Questions
Is inflammatory bowel disease curable?
Inflammatory bowel disease is not cured, but deep remission with no symptoms and a healed bowel lining is realistic for most patients with modern targeted therapy. Surgery can remove diseased segments but does not always cure Crohn disease.
Will I need a stoma bag?
Many patients never need a stoma. When colectomy is required for ulcerative colitis, an ileal pouch-anal anastomosis often allows life without a permanent bag. Stomas in Crohn disease are usually temporary in selected scenarios.
Can I have children safely?
Fertility is largely normal in inflammatory bowel disease in remission. Most biologic agents are continued through pregnancy under specialist guidance. Disease control before and during pregnancy is the most important factor for a healthy outcome.
What is the cancer risk?
Long-standing colonic inflammation increases colon cancer risk over decades. Surveillance colonoscopy starting eight to ten years after diagnosis, with shorter intervals in primary sclerosing cholangitis, has made this risk well managed.
Do diet and stress cause inflammatory bowel disease?
Diet and stress do not cause inflammatory bowel disease, but both influence flares and symptoms. A dietitian-guided plan, regular sleep, and stress support are part of long-term care alongside medication.
Are biologic agents safe in the long term?
Biologic agents have years of long-term safety data. The main risks are infection and rare allergic reactions. Pre-treatment screening for tuberculosis and hepatitis B, plus vaccination, makes long-term use very safe.
